U.S., Feb. 21 -- ClinicalTrials.gov registry received information related to the study (NCT06837155) titled 'A QT/QTc Evaluation Study of TS-172 in Healthy Adult Subjects' on Feb. 16.
Brief Summary: A clinical study to evaluate the effects on QT/QTc interval of TS-172 in healthy adults subjects
Study Start Date: March 03
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers
Intervention:
DRUG: TS-172 20 mg
oral administration of TS-172 20 mg
DRUG: TS-172 90 mg
oral administration of TS-172 90 mg
DRUG: Moxifloxacin
oral administration of moxifloxacin 400 mg
DRUG: Placebo
oral administration of placebo
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Taisho Pharmaceutical Co., Ltd.
Published by HT Digital Content Services w...